je.st
news
Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants
2015-03-13 20:18:18| Biotech - Topix.net
Galena Biopharma, Inc. , a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care, today announced the pricing of an underwritten public offering of 24,358,974 units at a public offering price of $1.56 per unit, for total gross proceeds of $38.0 million. Each unit consists of one share of common stock and a warrant to purchase 0.5 of a share of common stock at an exercise price of $2.08 per share.
Tags: public
stock
common
offering
Category:Biotechnology and Pharmaceuticals